Gastric cancer (GC) is one of the most common human cancers. Spheroid colony formation is an effective model for characterization of cancer stem cells. However, gene expression profiles of spheroid colonies obtained from GC cells have not been examined. We performed microarray analyses by Human Genome U133 Plus 2.0 Array in spheroid body-forming and parental cells from MKN-45 and MKN-74 GC cell lines. Kinesin family member C1 (KIFC1) was expressed >2-fold higher in spheroid body-forming cells than in parental cells in both GC lines. Both the number and size of spheres from MKN-45 cells were significantly reduced upon KIFC1 siRNA-transfection compared with negative control siRNA-transfection. Immunohistochemical analysis of 114 GC tissue samples revealed that 42 (37%) of GC cases were positive for KIFC1 expression. GC cases positive for KIFC1 were found more frequently in stage III/IV cases than in stage I/II cases. GC cases positive for KIFC1 were found more frequently in intestinal type GC cases than in diffuse type GC cases. Furthermore, KIFC1-positive GC cases showed high Ki-67 labeling index. Kaplan-Meier analysis demonstrated that KIFC1 expression was not associated with survival. We found positive expression of KIFC1 in CD44‑positive GC and aldehyde dehydrogenase 1 (ALDH1)-positive GC cells. Our results showed that KIFC1 is overexpressed in GC. Since knockdown of KIFC1 inhibited sphere formation, KIFC1 likely plays an important role in cancer stem cells.

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2016.4781DOI Listing

Publication Analysis

Top Keywords

kifc1 expression
12
cases positive
12
positive kifc1
12
kifc1
10
gastric cancer
8
cancer stem
8
cells
8
stem cells
8
spheroid body-forming
8
parental cells
8

Similar Publications

Article Synopsis
  • Breast cancer is highly prevalent, and resistance to cisplatin, a key chemotherapy drug, poses a significant challenge in treatment, prompting research into the role of KIFC1 in this resistance.
  • The study utilized various methods, including bioinformatics, chromatin immunoprecipitation, and qRT-PCR, to analyze the expression levels and mechanisms of KIFC1 and FOXD1 in breast cancer.
  • Findings revealed that FOXD1 enhances the expression of KIFC1, activating the glycolysis pathway, which contributes to the resistance of breast cancer cells to cisplatin, highlighting the FOXD1/KIFC1 axis as a potential target for improving treatment outcomes.
View Article and Find Full Text PDF

Patients diagnosed with soft tissue sarcoma (STS) often present at intermediate to advanced stages, with inherently limited therapeutic options available. There is an urgent need to identify novel therapeutic targets. In this study, by screening STS data from the Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) databases, KIFC1 is identified as a potential biomarker and a promising therapeutic target for STS.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the relationship between mitosis-related genes and clinical outcomes in colon cancer, aiming to create a predictive model to better understand tumor progression and immune responses.
  • Using data from 453 colon cancer patients, the researchers identified 17 key mitosis-related genes and developed a model that demonstrates strong predictive abilities for patient survival across different datasets.
  • The model also integrates factors like immune cell functions and provides tools (like nomograms) for predicting survival rates at 3, 5, and 7 years, showcasing its potential for improving colon cancer prognosis.
View Article and Find Full Text PDF

There are currently no approved targeted treatments for quadruple-negative breast cancer [QNBC; ER/PR/HER2/androgen receptor (AR)], a subtype of triple-negative breast cancer (TNBC). AR-low TNBC is more proliferative and clinically aggressive than AR-high TNBC. Centrosome amplification (CA), a cancer hallmark, is rampant in TNBC, where it induces spindle multipolarity-mediated cell death unless centrosome clustering pathways are co-upregulated to avert these sequelae.

View Article and Find Full Text PDF

MiR-105 exerts inhibitory effects on the development and progression of various cancers, including breast cancer, lung cancer, and gastric cancer. Through GEO data analysis, we observed decreased expression of miR-105 in liver cancer tissues compared to adjacent tissues. Furthermore, miR-105 downregulates KIFC1 expression levels by targeting its 3' UTR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!